OBN (UK) and Eurasante (France) are delighted to announce the launch of BioSeed, a joint venture event devised to provide a unique platform for early stage life science companies, technology transfer offices, and universities throughout Europe seeking equity investment from Angels, High-Net-Worth individuals, specialist crowd-funders, and PE/VX funders genuinely interested in Seed and Stage 1 funding of early-stage companies and organisations.

BioSeed will run as a one-day event and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.

Agenda

08:00-08:30 Registration & refreshments

08:30-08:45 Welcome & introductions

08:45-09:15 Investor perspective

09:15-12:15 Themed pitching presentations

12:15-13:30 Lunch & networking

13:30-17:15 One-to-one partnering

17:30 Networking drinks